Beyond Biopsy: Real-World Evaluation of the Fibrosis-6 Score in a Portuguese Cohort
GE - Portuguese Journal of Gastroenterology · 24.04.2026 · 33 (1) · 483-492
DOI: 10.1159/000552162 ↗Kurz gefasst
Fachartikel in der Zeitschrift GE - Portuguese Journal of Gastroenterology, online erschienen am 24.04.2026. Verfasst von Diogo Simas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Gastrenterologia, Unidade Local de Saúde Região de Leiria, Leiria, Portugal. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Liver fibrosis is a key determinant of morbidity and mortality in chronic liver disease. Noninvasive scores such as fibrosis-4 index (FIB-4) and AST-to-platelet ratio index (APRI) are widely used, but their accuracy varies across populations. Fibrosis-6 score (FIB-6), a novel composite biomarker incorporating age, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, platelet count, and albumin improves fibrosis prediction. This study evaluated the diagnostic performance of FIB-6 in a Portuguese cohort with steatotic liver disease.
Methods
This observational study analyzed 301 adult patients who underwent transient elastography. Demographic, clinical, and laboratory data were retrospectively collected. Noninvasive scores (FIB-4, APRI, and FIB-6) were calculated, and liver fibrosis (F0–F4) was assessed based on liver stiffness measure adjusted for liver disease etiology. Receiver operating characteristic (ROC) analyses, correlations with liver stiffness, Youden index-derived cutoffs, and rule-in/rule-out thresholds were subsequently performed. A subanalysis was also conducted for liver disease etiologies.
Results
FIB-6 correlated moderately with liver stiffness (r = 0.334; p < 0.001), significantly outperforming FIB-4 and APRI, which showed weak or nonsignificant correlations. Area under the ROC curve values for cirrhosis (F4) were 0.716 (FIB-6), 0.579 (APRI), and 0.513 (FIB-4); for advanced fibrosis (F3–F4), 0.709 (FIB-6), 0.568 (APRI), and 0.545 (FIB-4). Optimal Youden cutoffs for FIB-6 were >2.06 for advanced fibrosis and >1.69 for cirrhosis. A rule-in threshold of >2.30 achieved 90% specificity, while a rule-out threshold of
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Serviço de Gastrenterologia, Unidade Local de Saúde Região de Leiria, Leiria, Portugal.
Zitieren
APA
Simas, D., Gonçalves, A. R., Gomes, P., Caetano, I., Gomes, A. C., Russo, P., Atalaia-Martins, C., Cotrim, I., & Vasconcelos, H. (2026). Beyond Biopsy: Real-World Evaluation of the Fibrosis-6 Score in a Portuguese Cohort. GE - Portuguese Journal of Gastroenterology, 33(1), 483-492. https://doi.org/10.1159/000552162
Vancouver
Simas D, Gonçalves AR, Gomes P, Caetano I, Gomes AC, Russo P, et al. Beyond Biopsy: Real-World Evaluation of the Fibrosis-6 Score in a Portuguese Cohort. GE - Portuguese Journal of Gastroenterology. 2026;33(1):483-492. doi:10.1159/000552162
BibTeX
@article{Simas2026,
author = {Simas, Diogo and Gonçalves, André Ruge and Gomes, Plácido and Caetano, Isabel and Gomes, Ana Catarina and Russo, Pedro and Atalaia-Martins, Catarina and Cotrim, Isabel and Vasconcelos, Helena},
title = {Beyond Biopsy: Real-World Evaluation of the Fibrosis-6 Score in a Portuguese Cohort},
journal = {GE - Portuguese Journal of Gastroenterology},
year = {2026},
volume = {33},
number = {1},
pages = {483--492},
doi = {10.1159/000552162}
}
EUVIMED